journal article·2026-05-01Open access

Tuning magnetic behavior of Fe3O4 nanoparticles through oleic acid, PEG, and agar surface modifications

Togar Saragi, Firyal Arianna, G. A. Pramesti, Adi Sugiarto, Feni Rahmi, Hotmas D. Sinaga, Trisna Maulana, Utami Widyaiswari, Dita Puspita Sari, Risdiana, Isao Watanabe, Tadashi Adachi

AIP Advances· Volume 16· Issue 5

Abstract

In this study, magnetic nanoparticles were synthesized using co-precipitation method and, subsequently, surface modified it using oleic acid (OA), polyethylene glycol (PEG), and agar (AGAR). The novelty of this study lies in the implementation of four sequential steps of surface modification OA-PEG-AGAR-OA to enhance their suitability for biomedical applications. The key outcome is that surface modification significantly alters the magnetic behaviors of nanoparticles. First, the OA layer increased the magnetic saturation (Ms) from 23.36 emu/gr for bare Fe3O4 to 51.84 emu/gr for Fe3O4-OA—a value higher than some previous reports for Fe3O4-OA. However, subsequent coatings with PEG and AGAR led to a decrease in Ms due to the introduction of nonmagnetic domains, which reduce inter-particle magnetic interactions. Reintroducing OA at the final stage partially restored the Ms. All samples exhibited superparamagnetic-like behavior with coercive fields between 1.3 and 4.6 Oe, and near-zero coercivity and remanence, essential for preventing agglomeration. The time dependence of magnetization revealed slow relaxation times. Although slow relaxation aids magnetic targeting and control, it may prolong tissue interaction and risk overheating. For biomedical applications, nanoparticles should have a size of about 10 nm. The sizes of samples Fe3O4-OA (8.16 nm) and Fe3O4-OA/PEG (10.08 nm) are within this ideal range, while Fe3O4 (11.76 nm) is slightly above. The Fe3O4-OA/PEG/AGAR/OA sample had a significantly larger particle size of 30.21 nm. This implies an increase in magnetic anisotropy and interparticle interactions, causing its ZFC-FC branch point to shift to higher temperatures and preventing the observation of its blocking temperature below 300 K.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Characterization and Applications of Magnetic Nanoparticles · Nanoparticles: synthesis and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Faculty of Mathematics and Natural Sciences, Department of Physics, Universitas Padjadjaran 1 , Jl. Raya Bandung-Sumedang KM 21, Jatinangor, Sumedang 45363,

Faculty of Mathematics and Science Education, Physics Study Program, Universitas Pendidikan Indonesia 2 , Jl. Dr. Setiabudi No. 229, Isola, Sukasari, Bandung, West Java 40154,

College of Engineering, Shibaura Institute of Technology 3 , Saitama City, Saitama 337-8570,

Nuclear Structure Research Group, RIKEN Nishina Center 4 , 2-1 Hirosawa, Wako, Saitama 351-0198,

Department of Engineering and Applied Sciences, Sophia University 5 , 7-1 Kioi-cho, Chiyoda-ku, Tokyo 102-8554,

Funding

Direktorat Jenderal Penguatan Riset dan Pengembangan · Indonesian Endowment Fund for Education (LPDP) on behalf of the Indonesian Ministry of Higher Education, Science and Technology and managed under the EQUITY Program

References (32)

Show source-provided references
1. Synthesis of Fe3O4 nanoparticles with various size and magnetic properties by controlled hydrolysis10.1016/j.jcis.2007.05.047 ↗
2. Superparamagnetic iron oxide nanoparticles (SPION): From fundamentals to state-of-the-art innovative applications for cancer therapy10.3390/pharmaceutics15010236 ↗
3. Development of superparamagnetic iron oxide nanoparticles (SPIONS) for translation to clinical applications10.1109/TNB.2008.2011864 ↗
4. Utilization of superparamagnetic iron oxide nanoparticles (SPIONs) as a vector for drug delivery10.1007/s13204-023-02853-y ↗
5. Magnetic nanoparticles and targeted drug delivering10.1016/j.phrs.2010.01.014 ↗
6. Synthesis of size-controlled Fe3O4@SiO2 magnetic nanoparticles for nucleic acid analysis10.1166/jnn.2012.5170 ↗
7. Fe3O4 nanoparticles in targeted drug/gene delivery systems10.3390/ma11020324 ↗
8. Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system10.1016/j.jmmm.2005.01.064 ↗
9. Study of magnetic properties and relaxation time of nanoparticle Fe3O4-SiO210.3390/ma15041573 ↗
10. Weakly magnetic field-assisted synthesis of magnetite nano-particles in oxidative co-precipitation10.1016/j.partic.2009.03.005 ↗
11. Co-precipitation and magnetic properties of magnetite nanoparticles for potential biomedical applications10.15406/jnmr.2017.05.00118 ↗
12. Superparamagnetic iron oxide nanoparticles: Magnetic nanoplatforms as drug carriers10.2147/IJN.S30320 ↗
13. Engineered superparamagnetic iron oxide nanoparticles for externally controlled hyperthermia, drug delivery, and therapeutic toxicity10.33218/001c.37603 ↗
14. Surface modification of nanoparticles used in biomedical applications10.5772/50647 ↗
15. Synthesis and characterization of magnetic Fe3O4 nanoparticles using oleic acid as stabilizing agent10.31788/RJC.2019.1214082 ↗
16. Synthesis and characterization of magnetite nanoparticles via the chemical co-precipitation method10.1016/j.mseb.2012.01.003 ↗
17. Nylon-6-coated doxorubicin-loaded magnetic nanoparticles and nanocapsules for cancer treatment10.3390/magnetochemistry9040106 ↗
18. High drug capacity doxorubicin-loaded iron oxide nanocomposites for cancer therapy10.3390/magnetochemistry8050054 ↗
19. Tuning specific loss power of CoFe2O4 nanoparticles by changing surfactant concentration in a combined co-precipitation and thermal decomposition method10.1016/j.ceramint.2022.02.251 ↗
20. Synthesis and design of biologically inspired biocompatible iron oxide nanoparticles for biomedical applications10.1039/c5tb00931f ↗
21. Improving drug solutibility for oral delivery using solid dispersions10.1016/s0939-6411(00)00076-x ↗
22. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake10.1016/s0142-9612(01)00267-8 ↗
23. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications10.1016/j.biomaterials.2004.10.012 ↗
24. Agarose-based biomaterials for advanced drug delivery10.1016/j.jconrel.2020.07.028 ↗
26. Systematics of the spinel structure type10.1007/bf00307535 ↗
27. Interparticle interactions and magnetic anisotropy in ultrasmall iron oxide nanoparticles: Influence of molecular coating10.1021/cm203280y ↗
28. Biomedical nanomagnetics: A spin through possibilities in imaging, diagnostics, and therapy10.1109/tmag.2010.2046907 ↗
29. Magnetic field dependence of blocking temperature in oleic acid functionalized iron oxide nanoparticles10.1007/s10948-012-1559-4 ↗
30. Investigation of Brownian and Neel relaxation in magnetic fluids10.1016/s0304-8853(99)00065-7 ↗
31. Relaxation times in magnetic nanoparticles system and memory effects10.12693/APhysPolA.112.1203 ↗
32. The iron oxides strike back: From biomedical applications to energy storage devices and photoelectrochemical water splitting10.1002/adma.201101368 ↗